当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:110.49亿  总市值:110.49亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.19亿元,每股收益0.98元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益454147.57万元,未分配利润200268.65万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产564169.47万元,负债110021.90万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,782,020,224.831,223,284,970.75686,909,061.522,280,896,019.23
营业总成本1,468,536,204.53979,179,228.79538,737,974.71,966,937,346.46
营业利润340,804,804.26256,790,390.69154,276,662.98438,401,339.39
利润总额342,418,496.53258,868,887.07154,701,391.69434,491,209.43
净利润318,977,945.89239,137,127.93141,852,238.97412,058,658.76
其他综合收益-23,664,262.3-24,452,127.4212,754.54-43,521,492.11
综合收益总额295,313,683.59214,685,000.51141,864,993.51368,537,166.65
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,660,812,428.82,405,604,989.662,748,960,813.132,536,028,043.52
非流动资产合计2,980,882,308.023,181,116,685.132,937,874,816.022,989,654,525.15
资产总计5,641,694,736.825,586,721,674.795,686,835,629.155,525,682,568.67
流动负债合计948,841,682.54936,632,024.16987,889,894.8941,663,492.8
非流动负债合计151,377,325.7152,522,625.35142,448,597.74144,056,077.15
负债合计1,100,219,008.241,089,154,649.511,130,338,492.541,085,719,569.95
归属于母公司股东权益合计4,301,632,773.154,254,327,364.484,342,842,117.064,230,710,929.5
股东权益合计4,541,475,728.584,497,567,025.284,556,497,136.614,439,962,998.72
负债和股东权益合计5,641,694,736.825,586,721,674.795,686,835,629.155,525,682,568.67
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,654,629,831.451,088,512,990.31560,317,919.652,434,712,610.55
经营活动现金流出小计1,540,662,380.111,029,236,956.55483,112,922.832,185,448,075.96
经营活动产生的现金流量净额113,967,451.3459,276,033.7677,204,996.82249,264,534.59
投资活动现金流入小计2,056,540,467.271,296,735,713.19384,384,067.115,579,852,006.13
投资活动现金流出小计2,511,099,207.531,294,636,967.71391,913,472.065,327,095,930.88
投资活动产生的现金流量净额-454,558,740.262,098,745.48-7,529,404.95252,756,075.25
筹资活动现金流入小计10,550,00010,250,0005,170,00011,895,000
筹资活动现金流出小计230,530,706.38202,206,159.4325,666,108.43180,194,490.64
筹资活动产生的现金流量净额-219,980,706.38-191,956,159.43-20,496,108.43-168,299,490.64
汇率变动对现金及现金等价物的影响962,777.382,036,804.431,245,666.7-8,238,268.42
现金及现金等价物净增加额-559,609,217.92-128,544,575.7650,425,150.14325,482,850.78
期末现金及现金等价物余额697,037,346.281,128,101,988.441,307,071,714.341,256,646,564.2
最新报告期:2024-11-09
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华创证券郑辰,李婵娟1.301.601.952024-11-09
东吴证券张坤,朱国广1.311.581.872024-11-07
华创证券郑辰,李婵娟1.561.932.342024-09-15
中信证券宋硕,陈竹1.581.932.322024-09-10
东海证券杜永宏1.541.892.262024-08-27
TOP↑